Back to stock analysis

Scenario-based stock forecast

Research updated: Jul 11, 2026, 12:00 AM UTC

Eli Lilly and (LLY) Stock Forecast & Outlook

This outlook frames possible paths for Eli Lilly and; it is not a guaranteed price target or personalized investment advice.

Eli Lilly and Company is monitored through the lens of GLP-1 demand and pharmaceutical pipeline durability.

Base-case outlook

GLP-1 demand and pharmaceutical pipeline durability

Bull-case outlook

obesity drug adoption and pipeline expansion

Bear-case outlook

supply constraints and valuation expectations

What could invalidate the outlook

  • manufacturing capacity, pricing, trial data, and competition

Evidence and research sources

Lilly Reports First-Quarter 2026 Financial ResultsEli Lilly and Company · earningsVerified

Fetched: 7/11/2026, 12:00:00 AM UTC

Published: 4/30/2026, 12:00:00 AM

Open original source
Eli Lilly Investor RelationsEli Lilly and Company · companyVerified

Fetched: 7/11/2026, 12:00:00 AM UTC

Open original source
Form 10-Q for the Quarter Ended March 31, 2026Eli Lilly and Company · filingVerified

Fetched: 7/11/2026, 12:00:00 AM UTC

Published: 4/30/2026, 12:00:00 AM

Open original source
LLY editorial research profileAlphaVue Research · editorialVerified

Fetched: 7/11/2026, 12:00:00 AM UTC

Open earnings analysisOpen stock risks